A noninvasive genetic screening test to detect oral preneoplastic lesions

Parkin, 2001, Global cancer statistics in the year 2000, Lancet Oncol, 2, 533, 10.1016/S1470-2045(01)00486-7 Vokes, 1993, Head and neck cancer, N Engl J Med, 328, 184, 10.1056/NEJM199301213280306 Leemans, 1994, Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor, Cancer, 73, 187, 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J Wells, 2003, Tumours of the uterine cervix, 262 King, 1971, Cytology—its value in the diagnosis of oral cancer, Dent Clin N Am, 15, 817, 10.1016/S0011-8532(22)01457-4 Califano, 1996, Genetic progression model for head and neck cancer: implications for field cancerization, Cancer Res, 56, 2488 Braakhuis, 2003, A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications, Cancer Res, 63, 1727 Tabor, 2001, Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications, Clin Cancer Res, 7, 1523 Tabor, 2002, Multiple head and neck tumors frequently originate from a single preneoplastic lesion, Am J Pathol, 161, 1051, 10.1016/S0002-9440(10)64266-6 Van der Waal, 1997, Oral leukoplakia: a clinicopathological review, Oral Oncol, 33, 291, 10.1016/S1368-8375(97)00002-X Tabor, 2003, Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx, J Pathol, 199, 354, 10.1002/path.1285 Reibel, 2003, Prognosis of oral premalignant lesions: significance of clinical, histopathological, and molecular biological characteristics, Crit Rev Oral Biol Med, 14, 47, 10.1177/154411130301400105 Mao, 1996, Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment, Nature Med, 2, 682, 10.1038/nm0696-682 Rosin, 2000, Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia, Clin Cancer Res, 6, 357 Partridge, 2000, A case–control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization, Cancer Res, 60, 3893 Sudbø, 2001, DNA content as a prognostic marker in patients with oral leukoplakia, N Engl J Med, 344, 1270, 10.1056/NEJM200104263441702 Spafford, 2001, Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsattelite analysis, Clin Cancer Res, 7, 607 Rosin, 2002, 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites, Cancer Res, 62, 6447 Schouten, 2002, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acid Res, 30, e57, 10.1093/nar/gnf056 Pindborg, 1997, 21 Kutler, 2003, High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia, Arch Otolaryngol Head Neck Surg, 129, 106, 10.1001/archotol.129.1.106 Copper, 1995, Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck, Arch Otolaryngol Head Neck Surg, 121, 157, 10.1001/archotol.1995.01890020019005 Guo, 2001, Allelic loss in oratest-directed biopsies of patients with prior upper aerodigestive tract malignancy, Clin Cancer Res, 7, 1963